ALEC
$21.94
Alector
$2.11
10.64%
ALEC
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  $0.02
Revenue:  $25.56 Mil
Thursday
Feb 3
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, November 04, 2021

What do you expect when ALEC reports earnings?
Beat
Meet
Miss

Where is ALEC's stock price going from here?
Up
Flat
Down
Stock chart of ALEC
Analysts
Summary of analysts' recommendations for ALEC
Score
Grade
Pivots
Resistance
$21.58
$20.90
$20.37

$19.69

Support
$19.16
$18.48
$17.95
Tweet
Growth
Description
Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.